Dr. Hope Rugo, MD
Claim this profileUniversity of California San Francisco
Area of expertise
Breast Cancer
Hope Rugo, MD has run 19 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Hope Rugo, MD has run 5 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of California, San Francisco
UCSF Helen Diller Family Comprehensive Cancer Center
Clinical Trials Hope Rugo, MD is currently running
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial in participants with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the recommended Phase 2 dose (RP2D) of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, capivasertib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations.
Recruiting
1 award
Phase 1 & 2
Enzalutamide + Mifepristone or Chemotherapy
for Breast Cancer
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Recruiting
1 award
Phase 2
18 criteria
More about Hope Rugo, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Hope Rugo, MD has experience with
- Trastuzumab
- Avelumab
- Alpelisib
- Everolimus
- Exemestane
- Vinorelbine
Breakdown of trials Hope Rugo, MD has run
Breast Cancer
Breast cancer
No disease or condition mentioned.
Fibroblast Growth Factor Receptor 1 High Amplification
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hope Rugo, MD specialize in?
Hope Rugo, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Hope Rugo, MD currently recruiting for clinical trials?
Yes, Hope Rugo, MD is currently recruiting for 8 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Hope Rugo, MD has studied deeply?
Yes, Hope Rugo, MD has studied treatments such as Trastuzumab, Avelumab, Alpelisib.
What is the best way to schedule an appointment with Hope Rugo, MD?
Apply for one of the trials that Hope Rugo, MD is conducting.
What is the office address of Hope Rugo, MD?
The office of Hope Rugo, MD is located at: University of California San Francisco, San Francisco, California 94158 United States. This is the address for their practice at the University of California San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.